Centene Corporation which can be found using ticker (CNC) now have 18 market analysts covering the stock. The analyst consensus now points to a rating of ‘buy’. The range between the high target price and low target price is between 110 and 71 calculating the average target price we see $83.67. Now with the previous closing price of $66.06 this would imply there is now a potential upside of 26.7%. It’s also worth noting that there is a 50 day moving average of $66.77 and the 200 day MA is $72.29. The market cap for the company is 36.11B. The stock price for the company is currently is currently 65.8 USD
The potential market cap would be $45,734,793,091 based on the market consensus.
The company has a dividend yield of 1.57%. Other points of data to note are a P/E ratio of 24.83, revenue per share of 247.62 and a 3.68% return on assets.
Centene Corporation is a healthcare company. The Company provides services to government-sponsored and commercial healthcare programs, focusing on under-insured and uninsured individuals. It provides a range of managed healthcare products and services, primarily through Medicaid, Medicare, and commercial products. Its segments include Medicaid, Medicare, Commercial and Other. It offers Medicaid and Medicare members (including Medicare Prescription Drug Plans) as well as individuals and families served by the Health Insurance Marketplace and the TRICARE program. It also contracts with other healthcare and commercial organizations to provide a variety of specialty services focused on treating the whole person. Medicaid program provides health insurance to low-income families and individuals with disabilities. Medicare is a federal health insurance program for people ages 65 and over, which also covers people under 65 with certain disabilities and people with end-stage renal diseases.
